What are the recommended diuretics, dosing, and precautions for managing fluid retention or hypertension in pregnancy, including first-line thiazide therapy, use of loop diuretics for severe overload, and avoidance of potassium‑sparing agents?

Diuretics in Pregnancy

Diuretics are NOT recommended as first-line therapy for hypertension in pregnancy and should generally be avoided for routine management of fluid retention or blood pressure control. 1, 2

First-Line Antihypertensive Agents (NOT Diuretics)

The evidence-based first-line medications for hypertension in pregnancy are:

• Extended-release nifedipine (preferred due to once-daily dosing improving adherence)
• Labetalol (alternative if nifedipine causes headaches, tachycardia, or edema)
• Methyldopa (third option, though less favored in high-income countries) 1

These agents have the most robust safety and efficacy data, though the evidence remains relatively sparse. There is no compelling data supporting one agent over another between nifedipine and labetalol 1.

Why Diuretics Are Not Recommended

For Prevention of Preeclampsia

Thiazide diuretics should not be used to prevent preeclampsia. A Cochrane review of five trials (1,836 women) found no clear benefits for preventing preeclampsia (RR 0.68,95% CI 0.45-1.03), perinatal death, or preterm birth. Importantly, thiazides increased nausea/vomiting (RR 5.81) and treatment discontinuation due to side effects 3. The use of diuretics for prevention of preeclampsia cannot be recommended 3.

For Antepartum Hypertension Management

Current guidelines do not include diuretics as first-line or even second-line therapy for managing hypertension during pregnancy 1, 2. The theoretical concerns include:

• Reduction of plasma volume in women who may already be volume-depleted (particularly with preeclampsia)
• Potential for decreased placental perfusion
• Risk of electrolyte abnormalities

Evidence on Antepartum Use

A 2023 systematic review found that antepartum loop diuretics lowered diastolic blood pressure (mean difference -17.73 mmHg) and cardiac output, but there was insufficient evidence to suggest a clear benefit 4. The quality of evidence was limited by small studies with high heterogeneity.

Limited Role: Postpartum Hypertension

Loop diuretics may have a role in the immediate postpartum period for managing hypertension in women with hypertensive disorders of pregnancy, though the evidence quality is mixed.

Postpartum Evidence

• A 2025 meta-analysis (10 trials, 1,815 individuals) found that diuretics reduced hypertension within 2 weeks postpartum (RR 0.54,95% CI 0.39-0.74; NNT 4) 5
• However, when restricted to low-risk-of-bias trials only, this benefit was not statistically significant (RR 0.62,95% CI 0.36-1.09) 5
• A 2023 review showed postpartum loop diuretics reduced the need for additional antihypertensives (RR 0.69) but increased hospitalization duration 4
• No differences were found in severe maternal morbidity, readmissions, or breastfeeding 5

Postpartum Fluid Management

During labor and postpartum management of preeclampsia, total fluid intake should be limited to 60-80 mL/hour to avoid pulmonary edema risk. The goal is euvolemia—replacing insensible losses (30 mL/h) plus anticipated urinary losses (0.5-1 mL/kg/h). There is no rationale to "run dry" a preeclamptic woman as she is already at risk of acute kidney injury 2.

Specific Diuretic Considerations

Loop Diuretics (Furosemide)

• Not recommended as first-line therapy for hypertension in any population, including pregnancy 6
• Should be reserved for conditions of clinically significant fluid overload (heart failure, significant fluid retention with vasodilator drugs, advanced renal failure) 6
• May be considered postpartum in select cases with volume overload, though evidence is insufficient 4, 5

Thiazide Diuretics

• Contraindicated for routine use in pregnancy 7, 3
• Historical concerns about plasma volume reduction and placental perfusion remain relevant
• No outcome data support their use for hypertension management in pregnancy

Potassium-Sparing Diuretics

• Specifically avoid mineralocorticoid receptor antagonists (spironolactone, eplerenone) as they are contraindicated in pregnancy 1
• These agents fall under the same contraindication category as ACE inhibitors and ARBs due to concerns about fetal effects

Clinical Algorithm

For hypertension in pregnancy:

1. Start with extended-release nifedipine OR labetalol
2. If inadequate control, combine nifedipine + labetalol
3. Consider methyldopa as third-line
4. Do NOT use diuretics unless specific volume overload indication exists

For postpartum hypertension with volume overload:

1. Consider loop diuretic (furosemide) only if clear fluid overload present
2. Monitor closely for electrolyte abnormalities
3. Limit use to short-term management
4. Transition to standard antihypertensives (nifedipine, labetalol) for ongoing control

Key Caveats

• NSAIDs should be avoided in women with preeclampsia postpartum, especially with acute kidney injury, as they can worsen hypertension 2
• Blood pressure should be monitored at least every 4-6 hours during the day for at least 3 days postpartum 2
• Antihypertensives should be restarted after delivery and tapered slowly only after days 3-6 postpartum unless BP becomes low (<110/70 mmHg) 2
• The evidence base for diuretics in pregnancy remains limited, with most studies at high risk of bias 5